Melanoma: Biology & Patient Management 2018

Melanoma: Biology & Patient Management 2018 Banner

Date & Location
Saturday, October 13, 2018, 6:00 AM - 5:00 PM, Washington, DC

Target Audience
Dermatology, Emergency Medicine, Nuclear Medicine, Oncology, Pathology, Plastic Surgery, Radiation Oncology, Radiology, Surgery


Online registration is now closed. 

We will start on-site registration at 7:00 am. 

If you have a question about your current registration, please call us at (202) 780-1655 before 2:00 pm on Friday, October 12th, 2018. 

This interdisciplinary, one-day conference will examine clinical updates in melanoma biology staging and early disease management. In addition, revolutionary advances in the treatment of patients with high risk and metastatic disease will be discussed with a special emphasis on the multidisciplinary approach in the care of melanoma patients. This will include new data on the role of completion lymph node dissections, adjuvant therapy, the management of patients with brain metastases, duration of therapy, toxicity management and the revised AJCC staging system and the impact of all of these factors on patient management.  Case presentations and debates will address complex and controversial management issues in patients with high risk and advanced melanoma.


Physician Assistant:

  • Recognize treatment options for each stage of melanoma.
  • Recognize the importance of a multidisciplinary approach in management of patients with melanoma.
  • Identify which patients with melanoma should undergo a sentinel lymph node biopsy. 
  • Evaluate the role of immunotherapy in the setting of adjuvant therapy.
  • Recognize the various treatment options for patients with metastatic melanoma.
  • Define the protocol for posttreatment surveillance of patients with melanoma.


  1. Analyze and apply new insights in the diagnosis and treatment of advanced melanoma.
  2. Apply the 8th edition of the AJCC staging system, utilize appropriate staging modalities to correctly gauge patient risk of recurrence and death and choose most appropriate patient care strategy.
  3. Review and apply NCCN, SITC and AJCC and other guidelines for the pre-operative evaluation of melanoma patients including the indications for radiographic studies, such as PET and CT scans.
  4. Recognize the value of multidisciplinary evaluation and assessment , in contributing to more effective and expedited patient treatment.
  5. Assess new data on molecularly targeted therapies and novel immunotherapy in order to develop integrated treatment plans for patients with various molecular subtypes and stages of disease.
  6. Incorporate salvage surgery and targeted radiation in selected patients to enhance long term outcomes.
  7. Recognize the changing role completion lymph node dissection.
  8. Describe the new Data on choice of combination vs. single agent immunotherapy.
  9. Apply new Data on adjuvant and neoadjuvant therapy.
  10. Recognize new approaches to the management of patients with brain metastases

Registration Fees
  • Physician $150
  • Resident/Fellow $50
  • Physician Assistant $75
  • Nurse Practitioner $75
  • Nurse $75
  • Allied Health Professional $75


In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 7.25 Interprofessional Continuing Education (IPCE) credits for learning and change.